616
Views
42
CrossRef citations to date
0
Altmetric
Original Research

The cognitive impact of anticholinergics: A clinical review

, , , , , , , , , & show all
Pages 225-233 | Published online: 13 May 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (18)

Danica E. Johnson, Roger S. McIntyre, Rodrigo B. Mansur & Joshua D. Rosenblat. (2023) An update on potential pharmacotherapies for cognitive impairment in bipolar disorder. Expert Opinion on Pharmacotherapy 24:5, pages 641-654.
Read now
Lisandra Mendoza, Patricia Garcia, Ranjan Duara, Mónica Rosselli, David Loewenstein, Maria T. Greig-Custo, Warren Barker, Pamela Dahlin & Miriam J. Rodriguez. (2022) The effect of acculturation on cognitive performance among older Hispanics in the United States. Applied Neuropsychology: Adult 29:2, pages 163-171.
Read now
Satabdi Chatterjee, Ashna Talwar & Rajender R. Aparasu. (2020) Anticholinergic medications and risk of dementia in older adults: Where are we now?. Expert Opinion on Drug Safety 19:10, pages 1251-1267.
Read now
Asad Makhani, Miriam Thake & William Gibson. (2020) Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient. Clinical Interventions in Aging 15, pages 575-581.
Read now
Anastasiia S. Boiko, Svetlana A. Ivanova, Ivan V. Pozhidaev, Maxim B. Freidin, Diana Z. Osmanova, Olga Yu Fedorenko, Arkadyi V. Semke, Nikolay A. Bokhan, Bob Wilffert & Anton J. M. Loonen. (2020) Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors. The World Journal of Biological Psychiatry 21:1, pages 72-77.
Read now
Susan K. Shwartz, Robin D. Morris & Suzanne Penna. (2019) Psychometric properties of the Saint Louis University Mental Status Examination. Applied Neuropsychology: Adult 26:2, pages 101-110.
Read now
Veysi Çeri, Hasan Cem Aykutlu, Işık Görker, Ömer Faruk Akça, Mahmut Cem Tarakçıoğlu, Umut Mert Aksoy, Heysem Kaya, Merve Sertdemir, Ezgi İnce, Muhammed Tayyib Kadak, Gökşen Yüksel Yalçın, Cavid Guliyev, Ayhan Bilgiç, Elvan Çiftçi, Kinyas Tekin, Zehra Olcay Tuna, Burcu Oğuzdoğan, Nagihan Saday Duman, Bengi Semerci, Özden Şükran Üneri, Koray Karabekiroglu, Tuba Mutluer, Melike Nebioglu, Şaziye Senem Başgül, Mehmet İlkin Naharcı, Özgür Maden, Çiçek Hocaoğlu, Onur Durmaz, Haluk Usta, Şükriye Boşgelmez, Meltem Puşuroğlu, Hale Yapıcı Eser, Murat Kaçar, Mahmut Çakır, Hasan Turan Karatepe, Ümit Işık, Halil Kara, Çağdaş Hünkar Yeloğlu, Esra Yazıcı, Anıl Gündüz, Kader Semra Karataş, Figen Yavlal, Necati Uzun, Ahmet Bulent Yazici, Şahin Bodur, Esma Akpınar Aslan, Sedat Batmaz, Feyza Çelik, Sadettin Burak Açıkel, Zehra Topal, Neslihan Altunsoy, Özge Demircan Tulacı, Ömer Faruk Demirel, Serhat Çıtak, Halime Tuna Çak, Abdül Baki Artık, Adnan Özçetin, Ilker Özdemir, Fatma Gül Helvacı Çelik, Sadriye Ebru Çengel Kültür, Arif Çipil, Rukiye Ay, Ayşe Rodopman Arman, Kemal Utku Yazıcı, Arzu Erkan Yuce, İpek Perçinel Yazıcı, Emel Kurt, Anıl Şafak Kaçar, Nurhan Erbil, Cana Aksoy Poyraz, Gamze Ergil Altın, Berkan Şahin, Özge Kılıç, Şenol Turan, Memduha Aydın, Erkan Kuru, Abdullah Bozkurt, Hüseyin Güleç, Merve Yalçınay İnan, Ali Emre Şevik, Saliha Baykal, Yusuf Karaer, Omer Yanartaş, Hatice Aksu, Serhat Ergün, Aynur Görmez, Mesut Yıldız, Sevda Bag, Ferda Korkmaz Özkanoğlu, Mecit Caliskan, Alişan Burak Yaşar, Emre Konuk, Murat Altın, Serkut Bulut, Gresa Çarkaxhiu Bulut, Rıza Gökçer Tulacı, Neşe Yorguner Küpeli, Necati Enver, İlker Tasci, Ayşe Sakallı Kani, Bülent Bahçeci, Gülay Oğuz, Gülçin Şenyuva, Gülşen Teksin Ünal, Çiğdem Yektaş, Mehmet Hamdi Örüm, Erol Göka, Şakir Gıca, Özge Şahmelikoğlu, Gülser Şenses Dinç, Serpil Erşan, Erdal Erşan, Mehmet Fatih Ceylan, Selma Tural Hesapçıoğlu, Mustafa Solmaz, Yasin Hasan Balcioglu, Mesut Cetin, Musa Tosun, Nihal Yurteri, Sevinc Ulusoy, Mehmet Emrah Karadere, Yüksel Kivrak & Vahdet Görmez. (2018) Symposium Oral Presentations. Psychiatry and Clinical Psychopharmacology 28:sup1, pages 297-391.
Read now
Madia Lozupone, Francesco Panza, Eleonora Stella, Maddalena La Montagna, Paola Bisceglia, Giuseppe Miscio, Ilaria Galizia, Antonio Daniele, Lazzaro di Mauro, Antonello Bellomo, Giancarlo Logroscino, Antonio Greco & Davide Seripa. (2017) Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?. Expert Opinion on Drug Metabolism & Toxicology 13:3, pages 259-277.
Read now
L. Orsolini, C. Tomasetti, A. Valchera, R. Vecchiotti, I. Matarazzo, F. Vellante, F. Iasevoli, E. F. Buonaguro, M. Fornaro, A. L. C. Fiengo, G. Martinotti, M. Mazza, G. Perna, A. Carano, A. De Bartolomeis, M. Di Giannantonio & D. De Berardis. (2016) An update of safety of clinically used atypical antipsychotics. Expert Opinion on Drug Safety 15:10, pages 1329-1347.
Read now
Ganesh Thiagamoorthy, Linda Cardozo & Dudley Robinson. (2016) Current and future pharmacotherapy for treating overactive bladder. Expert Opinion on Pharmacotherapy 17:10, pages 1317-1325.
Read now
Patricia E. McLarin, Gregory M. Peterson, Colin M. Curtain, Prasad S. Nishtala, Paul J. Hannan & Ronald L. Castelino. (2016) Impact of residential medication management reviews on anticholinergic burden in aged care residents. Current Medical Research and Opinion 32:1, pages 123-131.
Read now
M. Sakel, A. Boukouvalas, R. Buono, M. Moten, F. Mirza, W.-Y. Chan, I. Maidment, J. Cross, T. O. Smith, P. K. Myint & C. Fox. (2015) Does anticholinergics drug burden relate to global neuro-disability outcome measures and length of hospital stay?. Brain Injury 29:12, pages 1426-1430.
Read now
Noll L Campbell, Todd C Skaar, Anthony J Perkins, Sujuan Gao, Lang Li, Babar A Khan & Malaz A Boustani. (2015) Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy. Clinical Interventions in Aging 10, pages 269-275.
Read now
P. Arvind Pala, B. N'Kaoua, J.-M. Mazaux, A. Simion, S. Lozes, E. Sorita & H. Sauzéon. (2014) Everyday-like memory and its cognitive correlates in healthy older adults and in young patients with traumatic brain injury: a pilot study based on virtual reality. Disability and Rehabilitation: Assistive Technology 9:6, pages 463-473.
Read now
Juanita Hoe, Claudia Cooper & Gill Livingston. (2013) An overview of the LASER-AD study: A longitudinal epidemiological study of people with Alzheimer's disease. International Review of Psychiatry 25:6, pages 659-672.
Read now
Philip Gerretsen & Bruce G Pollock. (2011) Drugs with anticholinergic properties: a current perspective on use and safety. Expert Opinion on Drug Safety 10:5, pages 751-765.
Read now
Nobuko Kemmotsu, Catherine C. Price, Genko Oyama, Michael S. Okun, Kelly D. Foote, Laura L. S. Howe & Dawn Bowers. (2011) Pre- and Post- GPi DBS Neuropsychological Profiles in a Case of X-Linked Dystonia-Parkinsonism. The Clinical Neuropsychologist 25:1, pages 141-159.
Read now
Malaz A. Boustani, Greg A. Sachs, Catherine A. Alder, Stephanie Munger, Cathy C. Schubert, Mary Guerriero Austrom, Ann M. Hake, Frederick W. Unverzagt, Martin Farlow, Brandy R. Matthews, Anthony J. Perkins, Robin A. Beck & Christopher M. Callahan. (2011) Implementing innovative models of dementia care: The Healthy Aging Brain Center. Aging & Mental Health 15:1, pages 13-22.
Read now

Articles from other publishers (24)

Connie Nicholls, Te-yuan Chyou & Prasad S Nishtala. (2023) Analysis of the nervous system and gastrointestinal adverse events associated with solifenacin in older adults using the US FDA adverse event reporting system. International Journal of Risk & Safety in Medicine 34:1, pages 63-73.
Crossref
Heiner Stuke. (2023) Markers of muscarinic deficit for individualized treatment in schizophrenia. Frontiers in Psychiatry 13.
Crossref
Michael Reisinger, Eva Z. Reininghaus, Johanna De Biasi, Frederike T. Fellendorf & Daniela Schoberer. (2022) Delirium‐associated medication in people at risk: A systematic update review, meta‐analyses, and GRADE ‐profiles . Acta Psychiatrica Scandinavica 147:1, pages 16-42.
Crossref
Chuan Tang, Ye Jin & Huan Wang. (2022) The biological alterations of synapse/synapse formation in sepsis-associated encephalopathy. Frontiers in Synaptic Neuroscience 14.
Crossref
Siddharth Marthi, Madison A. Pomerantz, Andrea J. Mernan & Yosef A. Berlow. (2022) The Twilight Zone: Oxybutynin Overuse Exacerbating Delirium. Journal of Geriatric Psychiatry and Neurology 35:6, pages 840-845.
Crossref
Annabelle Hook, Jessica L. Randall, Carla M. Grubb, Natalie Ellis, Jack Wellington, Aayushi Hemmad, Agisilaos Zerdelis, Andrew R. D. Winnett, Benjamin D. W. Geers, Bethany Sykes, Charlotte N. Auty, Cecilia Vinchenzo, Christiane E. Thorburn, Daniella Asogbon, Emily Granger, Heather Boagey, Juliet Raphael, Kajal Patel, Kartik Bhargava, Mary-Kate M. Dolley, Matthew J. Maden, Mehdin M. Shah, Qao M. Lee, Ratnaraj Vaidya, Simran Sehdev, Sneha Barai, Sophie Roche, Uzair Khalid, David A. Codling & Judith R. Harrison. (2022) Anti-cholinergic drug burden in patients with dementia increases after hospital admission: a multicentre cross-sectional study. BMC Geriatrics 22:1.
Crossref
Jordan R. Hill, Ephrem Abebe, Richard J. Holden, Anne Collins McLaughlin, Courtney C. Rogers & Nicole E. Werner. (2022) Reaching People Where They Are: Remote Macroergonomics Research. Proceedings of the Human Factors and Ergonomics Society Annual Meeting 66:1, pages 1617-1621.
Crossref
Giulia M. Giordano, Francesco Brando, Pasquale Pezzella, Maria De Angelis, Armida Mucci & Silvana Galderisi. (2022) Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature. Frontiers in Psychiatry 13.
Crossref
Ria Sanghavi, Tiberiu A. Pana, Hulkar Mamayusupova, Ian Maidment, Chris Fox, S. Matthijs Boekholdt, Mamas A. Mamas, Nicholas J. Wareham, Kay‐Tee Khaw & Phyo K. Myint. (2022) Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC‐Norfolk prospective population‐based cohort study. British Journal of Clinical Pharmacology 88:7, pages 3297-3306.
Crossref
Carlijn Wiersema, Richard C. Oude Voshaar, Rob H. S. van den Brink, Hans Wouters, Peter Verhaak, Hannie C. Comijs & Hans W. Jeuring. (2022) Determinants and consequences of polypharmacy in patients with a depressive disorder in later life. Acta Psychiatrica Scandinavica 146:1, pages 85-97.
Crossref
Bara'a Shawaqfeh, Carmel M. Hughes, Bernadette McGuinness & Heather E. Barry. (2022) A systematic review of interventions to reduce anticholinergic burden in older people with dementia in primary care. International Journal of Geriatric Psychiatry 37:6.
Crossref
Alina Schenk, Cosmin Octavian Popa & Cristiana Manuela Cojocaru. (2022) Emotional disorders associated to multiple sclerosis and psychological interventions: a literature review. Acta Marisiensis - Seria Medica 68:1, pages 6-11.
Crossref
Pedro Frias Gonçalves, Liliana Castro & Jorge Mota. (2021) Anticholinergic Plant Misuse and Schizophrenia: Regarding a Case Report. Revista Portuguesa de Psiquiatria e Saúde Mental 7:3, pages 117-119.
Crossref
Madeline A. VanDaele, Jordan O. Smith & Jessica Bovio Franck. (2021) Effectiveness of a clinical decision-support tool on adherence to prescribing and practice guidelines of high-risk antidepressant medications in geriatric patients. Mental Health Clinician 11:3, pages 181-186.
Crossref
. (2021) Delirium due to Anticholinergic Drug Burden in Older Persons. Advances in Geriatric Medicine and Research.
Crossref
. (2021) The Complexity of the Anticholinergic Burden in Frail Older Persons. Advances in Geriatric Medicine and Research.
Crossref
Nirit Tzur Efraim, Evgeniya Zikrin, David Shacham, Dori Katz, Evgeni Makulin, Leonid Barski, Lior Zeller, Carmi Bartal, Tamar Freud, Svetlana Lebedinski & Yan Press. (2020) Delirium in Internal Medicine Departments in a Tertiary Hospital in Israel: Occurrence, Detection Rates, Risk Factors, and Outcomes. Frontiers in Medicine 7.
Crossref
Fabio Del Bello, Alessandro Bonifazi, Gianfabio Giorgioni, Alessandro Piergentili, Maria Giovanna Sabbieti, Dimitrios Agas, Marzia Dell’Aera, Rosanna Matucci, Marcin Górecki, Gennaro Pescitelli, Giulio Vistoli & Wilma Quaglia. (2020) Novel Potent Muscarinic Receptor Antagonists: Investigation on the Nature of Lipophilic Substituents in the 5- and/or 6-Positions of the 1,4-Dioxane Nucleus. Journal of Medicinal Chemistry 63:11, pages 5763-5782.
Crossref
Katherine Graves-Morris, Carrie Stewart, Roy L. Soiza, Martin Taylor-Rowan, Terence J. Quinn, Yoon K. Loke & Phyo Kyaw Myint. (2020) The Prognostic Value of Anticholinergic Burden Measures in Relation to Mortality in Older Individuals: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 11.
Crossref
Charles M. Lepkowsky. 2019. Constipation. Constipation.
Adrian Wong, Angela Li, Kane Gill, Matthew P. Gray, Pamela L. Smithburger & Seohyun Claudia Choi. (2019) Drug-Associated Delirium Identified in The Food and Drug Administration Adverse Events Reporting System. Psychological Disorders and Research, pages 1-7.
Crossref
Jovan JavoracM.M., Gorana JanjićG.G., Dejan ŽivanovićB.B., Tijana JavoracM.M. & Ana MarkovićR.R.. (2019) The influence of typical and atypical antipsychotics on neurocognitive functions in patients with psychotic disorders. Hospital Pharmacology - International Multidisciplinary Journal 6:1, pages 765-773.
Crossref
Esperanza Navarro-Pardo, Carol A. Holland & Antonio Cano. (2018) Sex Hormones and Healthy Psychological Aging in Women. Frontiers in Aging Neuroscience 9.
Crossref
Jin-Woo Park. (2013) The Effect of Solifenacin on Cognitive Function following Stroke. Dementia and Geriatric Cognitive Disorders Extra 3:1, pages 143-147.
Crossref